Pre-Clinical Activity of Tipifarnib in Cutaneous T-Cell Lymphoma

Volume: 18, Pages: S283 - S284
Published: Sep 1, 2018
Abstract
Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin lymphoma characterized by malignant infiltration of skin-homing T-cells manifesting clinically as patches and plaques on the skin. The most common type of CTCL is an indolent, skin-limited form called mycosis fungoides (MF) which may progress to an aggressive leukemic variant, Sézary Syndrome (SS). As there are few effective therapies available for advanced-stage CTCL, we sought to...
Paper Details
Title
Pre-Clinical Activity of Tipifarnib in Cutaneous T-Cell Lymphoma
Published Date
Sep 1, 2018
Volume
18
Pages
S283 - S284
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.